[0]Top News
[1]Oddly Enough
[2]Sports
[3]Entertainment
[4]Business
[5]Investing
[6]Technology
[7]Internet
[8]World
[9]US News
Science
Politics
Health
Interstate Highway Travel Guide
Health
No heart benefit seen with fibrates in diabetics
ATLANTA (Reuters) - Adding a triglyceride-lowering drug to cholesterol-fighting statins provided no additional protection from heart attack, stroke and death from heart disease in patients with Type 2 diabetes, according to data from a large study.
Abbott's heart valve device proves safe, effective
ATLANTA (Reuters) - An experimental, minimally invasive technique to repair the most common type of heart valve problem proved to be far safer and nearly as effective as open heart surgery, meeting the primary goals of a pivotal study, researchers said on Sunday.
Novartis drugs fail to help high-risk patients
ATLANTA (Reuters) - The Novartis diabetes drug Starlix failed to reduce progression to the disease or cut down on serious heart problems in patients at high risk for both diabetes and heart disease, according to a large study released on Sunday.
U.S. court rules again against vaccine-autism claims
WASHINGTON (Reuters) - Vaccines that contain a mercury-based preservative called thimerosal cannot cause autism on their own, a special U.S. court ruled on Friday, dealing one more blow to parents seeking to blame vaccines for their children's illness.
Women on the pill live longer: study
LONDON (Reuters) - One of the world's largest studies of the contraceptive pill has found that women who have taken it can expect longer lives and are less likely to die from any cause, including cancer and heart disease.
Plavix gets new FDA warning
WASHINGTON (Reuters) - The blockbuster anti-clotting drug Plavix will carry a new warning about patients who have a poor response to the drug because they do not break it down well, U.S. regulators said on Friday.
House panel to consider healthcare bill Monday
WASHINGTON (Reuters) - The House of Representatives Budget Committee on Monday will consider a reconciliation bill that Democrats hope clears the way for final congressional approval of an overhaul of U.S. healthcare, House Democratic Leader Steny Hoyer said on Friday.
Rates of food sensitivity vary by country: study
NEW YORK (Reuters Health) - People in Portland are more likely than those in Iceland to be sensitive to certain foods, but reactions to fish, eggs and cow's milk appear rare in both places, new research suggests.
Glenn Close has genes mapped
CHICAGO (Reuters) - Archbishop Desmond Tutu has done it. So has genome pioneer Craig Venter. And now American film actress Glenn Close has joined a handful of celebrities to have their genome sequenced in the name of science.
Kids outgrow growing pains: study
NEW YORK (Reuters Health) - Most youngsters grow out of having otherwise unexplained bone and muscle aches known as growing pains, researchers from Israel report.
Q+A: Obama tries to avoid distractions
WASHINGTON (Reuters) - President Barack Obama and his Democrats are trying to avoid distractions within their own party in their quest to gain passage of a U.S. healthcare overhaul and pursue other big items on their agenda.
Calcium may help you live longer: study
NEW YORK (Reuters Health) - Getting a bit more calcium in your diet could help you live longer, new research suggests.
Democrats move closer to healthcare deal
WASHINGTON (Reuters) - Congressional Democrats drew closer on Thursday to agreement on a broad healthcare overhaul that could lead to a final vote in the next few weeks, but vowed not to be bound by White House deadlines.
Drugmakers agree on landmark vaccines deal for poor
LONDON (Reuters) - Several drug firms have agreed on a landmark deal to supply up to 200 million doses a year of cut-price pneumococcal vaccines to developing nations, according to the global immunization alliance that is overseeing the deal.
U.S. safety panel says big Vytorin study can go on
NEW YORK (Reuters) - Merck & Co on Thursday said an independent data safety monitoring board has approved continuation of a big study meant to determine whether its blockbuster Vytorin cholesterol drug prevents heart attacks and stroke.
Neoprobe says radioactive tracing agent's NDA on track
(Reuters) - Diagnostics products maker Neoprobe Corp said U.S. health regulators have indicated that data from a late-stage trial of its radioactive tracing agent would support filing for marketing approval.
Big first trimester weight gain ups diabetes risk
NEW YORK (Reuters Health) - Women who gain weight too quickly during the first three months of pregnancy are more prone to develop pregnancy-related diabetes, new research shows.
U.S. children turn to inhaling to get high: study
WASHINGTON (Reuters) - More 12-year-olds in the United States admit to using potentially deadly inhalants to get high than have used marijuana, cocaine and hallucinogens combined, U.S. health officials said on Thursday.
Scientists find "mother" of all skin cells
LONDON (Reuters) - Scientists have found the "mother," or origin, of all skin cells and say their discovery could dramatically improve skin treatments for victims of serious wounds and burns.
Do needle-exchange programs really work?
NEW YORK (Reuters Health) - Needle-exchange programs designed to cut injection drug users' risk of HIV, the virus that causes AIDS, and other infections do seem to reduce needle sharing, but there is only limited evidence that they lower disease transmission, a new research review concludes.
Interstate Highway Travel Guide
©Copyright OnlineNews.mobi